GSK.NYSEGsk PLC
13F-HR: GSK 13F Holdings — June 30, 2026
Institutional Holdings Report (13F)
GSK plc reported 13 holdings worth $602.2M for the period ended June 30, 2026.
Summary
- GSK plc reported 13 holdings worth $602.2M as of June 30, 2026.
- CRISPR THERAPEUTICS AG — $175.7M (29.17%), 3,220,627 SH.
- WAVE LIFE SCIENCES LTD — $106.0M (17.6%), 18,245,691 SH.
- VIR BIOTECHNOLOGY INC — $87.1M (14.47%), 8,550,954 SH.
- BIONTECH SE — $82.8M (13.75%), 889,824 SH.
- IDEAYA BIOSCIENCES INC — $49.7M (8.25%), 1,333,333 SH.
Top Holdings
GSK plc · 13 positions · $602.2M total · as of June 30, 2026
| Issuer | Value | % Port. | Shares |
|---|---|---|---|
| CRISPR THERAPEUTICS AG | $175.7M | 29.17% | 3,220,627 |
| WAVE LIFE SCIENCES LTD | $106.0M | 17.6% | 18,245,691 |
| VIR BIOTECHNOLOGY INC | $87.1M | 14.47% | 8,550,954 |
| BIONTECH SE | $82.8M | 13.75% | 889,824 |
| IDEAYA BIOSCIENCES INC | $49.7M | 8.25% | 1,333,333 |
| CYTOKINETICS INC | $29.0M | 4.82% | 340,434 |
| LYELL IMMUNOPHARMA INC | $21.3M | 3.53% | 1,512,659 |
| SPERO THERAPEUTICS INC | $20.3M | 3.37% | 9,190,606 |
| NKARTA INC | $8.9M | 1.48% | 3,150,732 |
| FULCRUM THERAPEUTICS INC | $6.5M | 1.09% | 1,785,714 |
Keywords
13F, institutional holdings, GSK plc, CRISPR THERAPEUTICS AG, WAVE LIFE SCIENCES LTD, VIR BIOTECHNOLOGY INC, BIONTECH SE, IDEAYA BIOSCIENCES INC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.